Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...

The Effect of Aging on Tissues

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...

Life Tables

Life Tables

A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Aging of budding yeast.

Rejuvenation research·2012

Same author

Mitochondrial translocation in young and old cells.

Rejuvenation research·2010

Same author

Makeham's addition to the Gompertz law re-evaluated.

Biogerontology·2008

Same author

Accumulating insoluble protein and rate of aging.

Rejuvenation research·2008

Same author

Gompertz law and aging as exclusion effects.

Biogerontology·2007

Same author

Accumulation of insoluble protein and aging.

Biogerontology·2002

Search research articles

Related Experiment Video

Updated: Jul 15, 2026

Measurement of Lifespan in Drosophila melanogaster

Measurement of Lifespan in Drosophila melanogaster

Published on: January 7, 2013

Gompertz law and aging as exclusion effects.

Anund Hallén¹

¹Department of Medical Biochemistry and Microbiology, Biomedical Center, University of Uppsala, Box 582, 75123 Uppsala, Sweden. anund.hallen@swipnet.se

|May 1, 2007

Summary

Aging rate, measured by Gompertz slope (alpha), may correlate with the accumulation of insoluble protein networks. This accumulation logarithmically decreases water available to macromolecules, potentially explaining aging dynamics.

Area of Science:

Gerontology
Biophysics
Biochemistry

Context:

The Gompertz law describes the exponential increase in mortality rate with age, suggesting aging involves exponential or logarithmic dynamics.
The Gompertz slope (alpha) is a potential indicator of aging rate in homogeneous populations.
Current models lack insight into the underlying causes of aging.

Purpose:

To explore a potential correlation between the Ogston-Laurent exclusion equation and human aging.
To propose a biophysical model for aging based on protein network accumulation.

Summary:

This study examines the relationship between the Ogston-Laurent exclusion equation and human aging.
It posits that aging involves the formation of an inert, cross-linked, insoluble protein network that increases with age.

More Related Videos

Studying Age-dependent Genomic Instability using the S. cerevisiae Chronological Lifespan Model

Studying Age-dependent Genomic Instability using the S. cerevisiae Chronological Lifespan Model

Published on: September 29, 2011

Quantifying Yeast Chronological Life Span by Outgrowth of Aged Cells

Quantifying Yeast Chronological Life Span by Outgrowth of Aged Cells

Published on: May 6, 2009

Related Experiment Videos

Last Updated: Jul 15, 2026

Measurement of Lifespan in Drosophila melanogaster

Measurement of Lifespan in Drosophila melanogaster

Published on: January 7, 2013

Studying Age-dependent Genomic Instability using the S. cerevisiae Chronological Lifespan Model

Studying Age-dependent Genomic Instability using the S. cerevisiae Chronological Lifespan Model

Published on: September 29, 2011

Quantifying Yeast Chronological Life Span by Outgrowth of Aged Cells

Quantifying Yeast Chronological Life Span by Outgrowth of Aged Cells

Published on: May 6, 2009

This network accumulation leads to a logarithmic reduction in water available to colloidal macromolecules, with alpha reflecting the rate of polypeptide network accumulation.

Impact:

Provides a novel biophysical perspective on aging mechanisms.
Suggests a quantifiable link between protein aggregation and aging rate.
Offers a potential framework for understanding age-related decline in vitality and viability.